Takahara Makoto
Department of Internal Medicine, Nishi-Kofu National Hospital.
Kekkaku. 2004 Dec;79(12):711-6.
We evaluated the cause of death in patients with active tuberculosis.
40 patients (male 32, female 8, mean age 76 years old), died under treatment for tuberculosis during 1999 to 2002 in our hospital, were analized. We compared patients' backgrounds, complications, extent of pulmonary tuberculosis, and outcome of the treatment between 40 died cases and 162 patients who were supposed to be successfully treated by cohort analysis (control group).
17 cases died of tuberculosis and 23 cases died of non-tuberculous diseases. Pneumonia occupied the top (9 cases) in the latter group. Died cases were higher in age and showed larger performance status score than the control group. Further, laboratory findings revealed poorer nutritional conditions and higher inflammatory reactions in the died group. The duration of symptoms before admission seemed to be longer in the died group, however, the difference with the control was not significant. All of the died group had complications and the rate of having liver diseases and cerebrovascular diseases was higher than that of the control group. Furthermore, the extent of lung lesions was more extensive in the died group. The frequency of changing drugs due to side effects was higher in the died group, therefore, the proportion of cases completed the standard treatment was lower in the died group.
Impossibility of continuing the standard treatment gave unfavorable impact in the died cases rather than the delay in their admission. Due to the above reasons, negative conversion of their sputum culture was difficult, and they died of tuberculosis directly or indirectly. Some of the patients who died of pneumonia (non-tuberculous death) might be included in cases died of tuberculosis.
我们评估了活动性肺结核患者的死亡原因。
对1999年至2002年期间在我院接受肺结核治疗期间死亡的40例患者(男性32例,女性8例,平均年龄76岁)进行了分析。通过队列分析,我们比较了40例死亡病例与162例预计成功治愈的患者(对照组)之间的患者背景、并发症、肺结核范围及治疗结果。
17例死于肺结核,23例死于非结核性疾病。后者中肺炎位居首位(9例)。死亡病例的年龄高于对照组,且表现状态评分更高。此外,实验室检查结果显示死亡组的营养状况较差,炎症反应较高。死亡组入院前症状持续时间似乎更长,然而与对照组的差异并不显著。所有死亡组均有并发症,且患肝病和脑血管疾病的比例高于对照组。此外,死亡组的肺部病变范围更广。死亡组因副作用换药的频率更高,因此,死亡组完成标准治疗的病例比例更低。
无法继续标准治疗对死亡病例产生了不利影响,而非入院延迟。由于上述原因,他们的痰培养转阴困难,直接或间接死于肺结核。一些死于肺炎(非结核性死亡)的患者可能被纳入死于肺结核的病例中。